Fortis Healthcare share price touched a 52-week high of Rs 265.75, rising 3 percent in the early trade on August 17.
Research house Goldman Sachs has maintained a buy call on the stock with a target at Rs 295 a share. It has raised FY23-24 EPS estimates by up to 13 percent while retaining a constructive view.
There is an improving mix in the hospital occupancy and B2C push in diagnostics leading to narrow operating metrics gap versus the peers. However, there’s a scope for turning around laggard hospitals, it added.
The share price of the hospital chain has risen more than 90 percent in the last year.
